From the clinical voice to strategic clarity
Healthcare-professional perspectives are scattered across publications, congresses, scientific discussions, educational programmes and digital channels. Conventional monitoring tells you what is being discussed — not why HCPs hold a view, how strongly the evidence supports it, or what it means for your strategy. We bring these signals together, calibrate them against the scientific evidence and translate them into intelligence medical and brand teams can act on.
Strategic advisory
Before any deliverable is scoped, our consultants work with your leadership to answer the questions that determine whether the evidence will change a decision.
- HCP intelligence strategy: which clinical questions, segments and channels matter for your asset, indication or landscape
- Evidence calibration — separating clinical conviction backed by data from sentiment that is not, and locating consensus versus controversy
- Treatment-adoption diagnosis: barriers, accelerators and the evidence or education gaps behind them
- Medical and strategic prioritisation: translating HCP intelligence into field-medical, scientific-communication and evidence-generation plans
Evidence generation capabilities
HCP Perception Landscape
Structured synthesis of clinician opinions, questions, concerns and clinical reasoning across professional segments and geographies.
Congress & Scientific Discourse Analysis
Abstracts, posters, proceedings and expert discussion mined for emerging narratives, unanswered questions and shifts in consensus.
Educational Intelligence
Analysis of CME programmes, webinars and symposia to reveal how the science is being taught — and where education gaps remain.
Evidence-Calibrated Sentiment
HCP sentiment linked to the underlying publications, guidelines and trial data, so conviction is weighed against evidence strength.
Competitive Narrative Tracking
How HCPs position your asset against competitors, and which emerging narratives are gaining or losing clinical support.
Pilot Intelligence Assessment
A focused, evidence-calibrated assessment for one asset, indication or therapeutic landscape — with source-traceable findings and recommendations.
Move from observation to action
More information does not always mean greater insight. HCP conversations are fragmented, context-dependent and difficult to interpret at scale. Our approach connects the collective clinical voice with the broader scientific and competitive landscape so that every finding explains not just what clinicians say, but why — and what to do about it.
Understand evolving perceptions
Track how clinician views on efficacy, safety, place in therapy and guideline fit develop over time and across segments.
Explain adoption behaviour
Identify the barriers and accelerators behind prescribing decisions — and whether they are rooted in evidence, experience or education.
Reveal consensus and controversy
Locate where the clinical community agrees, where it is divided, and which evidence would move the debate.
Detect evidence and education gaps
Surface the questions HCPs are asking that current data or medical education do not yet answer — the raw material for your evidence and communication plans.
- 01Scope the clinical questions, segments and landscape
- 02Unify HCP, scientific, congress, educational and competitive streams
- 03AI-assisted extraction of opinions, reasoning and sentiment
- 04Calibrate every signal against the underlying evidence, with expert clinical review
- 05Translate into prioritised medical and strategic recommendations
- HCP perception & adoption landscape
- Consensus–controversy map
- Evidence & education gap analysis
- Competitive narrative assessment
- Source-traceable intelligence report with recommendations
AI-assisted strategic analysis
Not every project needs it. For the engagements below, our consultants draw on in-house AI tools to analyse faster and more consistently — and you receive the insight as a strategic report with recommendations.
HCP intelligence assessment
For assets where treatment adoption or medical strategy hinges on clinician opinion, we use in-house AI tools to unify HCP conversations, congress, educational and scientific evidence streams — with expert review — into a calibrated, source-traceable intelligence report.
Consensus–controversy mapping
Where the clinical community is divided, we quantify where HCP opinion converges and diverges by segment and geography, link each position to the evidence behind it, and identify which data or education would move the debate.
Questions clients ask about HCP Voice & Intelligence
HCP intelligence is most actionable when paired with our US Market Access & Pricing Policy, EU HTA & Joint Clinical Assessment and HEOR & Global Market Access Strategy capabilities.
How is HCP intelligence different from market research?+
Rather than asking a sample of clinicians what they think, we synthesise what they already say across publications, congresses, education and digital channels — and calibrate each view against the underlying evidence.
What decisions does HCP intelligence inform?+
Field-medical priorities, scientific communication plans, evidence-generation gaps, launch positioning and competitive narrative response.
Can you start with a pilot?+
Yes — a focused, evidence-calibrated assessment for one asset, indication or therapeutic landscape with source-traceable findings and recommendations.
Scope a HCP Voice & Intelligence engagement
Share your objectives, timelines and target markets. We respond within one business day with next steps.